NCT04186637 An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT04169321 Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors Status COMPLETED Phase PHASE1
NCT04167137 Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants Status TERMINATED Phase PHASE1
NCT04163575 Immunotherapy With CD22 CAR T-cells for B-Cell Lymphoma, ALL and CLL Status UNKNOWN Phase PHASE1/PHASE2
NCT04154228 Non-invasive Evaluation of Lymphoma Patients Based on Artificial Intelligence and PET/MRI Status UNKNOWN Phase NA
NCT04144140 Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101 Status TERMINATED Phase PHASE1
NCT04132843 Novel MRI Techniques for the Characterization and Treatment Assessment of High Grade Brain Lesions Status COMPLETED Phase NA
NCT04119154 Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza) Status COMPLETED Phase NA
NCT04111107 Precision Medicine for Patients With Identified Actionable Mutations Status TERMINATED Phase PHASE2
NCT04106167 Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy Status TERMINATED Phase N/A
NCT04094610 A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations Status RECRUITING Phase PHASE1/PHASE2
NCT04088864 CD22-CAR T Cells in Children and Young Adults With B Cell Malignancies Status COMPLETED Phase PHASE1
NCT04081779 Survivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT Study Status COMPLETED Phase NA
NCT04074213 Clozapine and Haematologic Malignancies: Observational and Retrospective Study Using the WHO Pharmacovigilance Database Status UNKNOWN Phase N/A
NCT04069845 A Registry Study in Lymphoma Patients Treated With Liposomal Doxorubicin Status UNKNOWN Phase N/A
NCT04062877 Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma Status COMPLETED Phase N/A
NCT04053439 Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications Status RECRUITING Phase N/A